`

Compugen

Biotechnology Research

Specialities :
Immuno-oncology; computational biology; dnam-1 axis; innovation
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$20.0M
size-icon Size
51 - 200

Frequently Asked Questions About Compugen

What does Compugen do?+

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has developed two proprietary product candidates: COM701, a potential first-in-class anti-PVRIG antibody and COM902, a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors. Compugen also has a clinical stage partnered program, rilvegostomig (previously AZD2936), a PD-1/TIGIT bispecific antibody where the TIGIT component is derived from Compugens clinical stage anti-TIGIT antibody, COM902, in Phase 3 development by AstraZeneca through a license agreement for the development of bispecific and...

What are Compugen's specialties? +

Immuno-oncology; computational biology; dnam-1 axis; innovation

What is Compugen's industry? +

Compugen operates in the Biotechnology research industry.

What is Compugen's revenue? +

Compugen's revenue is 11m - 100m

What is Compugen's company size? +

Compugen has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.